Key clinical point: Bleeding score assessed with the ISTH-BAT may help identify or assess hemophilia patients, regardless of whether clotting factor levels are known.
Major finding: Bleeding scores were a mean of 13.5 and 13.2 for hemophilia A and B patients, respectively, and 0.8 for healthy male controls (P less than .001).
Study details: A cross-sectional study included 115 adult and pediatric patients with hemophilia A or B treated in Pakistan between 2014 and 2016.
Disclosures: The authors reported having no conflicts of interest.
Borhany M et al. Transfus Apher Sci. 2018 Aug;57(4):556-60.